121 related articles for article (PubMed ID: 19656574)
1. Emotional disorders in testicular cancer survivors in relation to hypogonadism, androgen receptor polymorphism and treatment modality.
Eberhard J; Ståhl O; Cohn-Cedermark G; Cavallin-Ståhl E; Giwercman Y; Rastkhani H; Rylander L; Eberhard-Gran M; Kvist U; Giwercman A
J Affect Disord; 2010 May; 122(3):260-6. PubMed ID: 19656574
[TBL] [Abstract][Full Text] [Related]
2. [Evaluation of quality of life, anxiety and depression in testicular cancer patients during chemotherapy and after anticancer treatment].
Osmańska M; Borkowska A; Makarewicz R
Psychiatr Pol; 2010; 44(4):543-56. PubMed ID: 20919505
[TBL] [Abstract][Full Text] [Related]
3. The quality of life and hormonal disturbances in testicular cancer survivors in Cisplatin era.
Wiechno P; Demkow T; Kubiak K; Sadowska M; Kamińska J
Eur Urol; 2007 Nov; 52(5):1448-54. PubMed ID: 17544206
[TBL] [Abstract][Full Text] [Related]
4. Genetic variations associated with the effect of testicular cancer treatment on gonadal hormones.
Aschim EL; Oldenburg J; Kristiansen W; Giwercman A; Witczak O; Fosså SD; Haugen TB
Hum Reprod; 2014 Dec; 29(12):2844-51. PubMed ID: 25336703
[TBL] [Abstract][Full Text] [Related]
5. Polymorphic variation in the androgen receptor gene: association with risk of testicular germ cell cancer and metastatic disease.
Västermark Å; Giwercman YL; Hagströmer O; Rajpert De-Meyts E; Eberhard J; Ståhl O; Cedermark GC; Rastkhani H; Daugaard G; Arver S; Giwercman A
Eur J Cancer; 2011 Feb; 47(3):413-9. PubMed ID: 20880698
[TBL] [Abstract][Full Text] [Related]
6. Linkage between androgen receptor gene CAG trinucleotide repeat length and testicular germ cell cancer histological type and clinical stage.
Giwercman A; Lundin KB; Eberhard J; Ståhl O; Cwikiel M; Cavallin-Ståhl E; Giwercman YL
Eur J Cancer; 2004 Sep; 40(14):2152-8. PubMed ID: 15341991
[TBL] [Abstract][Full Text] [Related]
7. Impact of therapy and androgen receptor polymorphism on sperm concentration in men treated for testicular germ cell cancer: a longitudinal study.
Eberhard J; Ståhl O; Giwercman Y; Cwikiel M; Cavallin-Ståhl E; Lundin KB; Flodgren P; Giwercman A
Hum Reprod; 2004 Jun; 19(6):1418-25. PubMed ID: 15105386
[TBL] [Abstract][Full Text] [Related]
8. Hypogonadism and androgen deficiency symptoms in testicular cancer survivors.
Lackner JE; Märk I; Schatzl G; Marberger M; Kratzik C
Urology; 2007 Apr; 69(4):754-8. PubMed ID: 17445664
[TBL] [Abstract][Full Text] [Related]
9. The androgen receptor CAG repeat polymorphism and risk of breast cancer in the Nurses' Health Study.
Haiman CA; Brown M; Hankinson SE; Spiegelman D; Colditz GA; Willett WC; Kantoff PW; Hunter DJ
Cancer Res; 2002 Feb; 62(4):1045-9. PubMed ID: 11861380
[TBL] [Abstract][Full Text] [Related]
10. Polymorphic CAG and GGN repeat lengths in the androgen receptor gene and prostate cancer risk: a population-based case-control study in China.
Hsing AW; Gao YT; Wu G; Wang X; Deng J; Chen YL; Sesterhenn IA; Mostofi FK; Benichou J; Chang C
Cancer Res; 2000 Sep; 60(18):5111-6. PubMed ID: 11016637
[TBL] [Abstract][Full Text] [Related]
11. Androgen, progesterone, and FSH receptor polymorphisms in ovarian cancer risk and outcome.
Ludwig AH; Murawska M; Panek G; Timorek A; Kupryjanczyk J
Endocr Relat Cancer; 2009 Sep; 16(3):1005-16. PubMed ID: 19458022
[TBL] [Abstract][Full Text] [Related]
12. Sexual function in men treated for testicular cancer.
Eberhard J; Ståhl O; Cohn-Cedermark G; Cavallin-Ståhl E; Giwercman Y; Rylander L; Eberhard-Gran M; Kvist U; Fugl-Meyer KS; Giwercman A
J Sex Med; 2009 Jul; 6(7):1979-89. PubMed ID: 19453896
[TBL] [Abstract][Full Text] [Related]
13. Symptomatic hypogonadism in male survivors of cancer with chronic exposure to opioids.
Rajagopal A; Vassilopoulou-Sellin R; Palmer JL; Kaur G; Bruera E
Cancer; 2004 Feb; 100(4):851-8. PubMed ID: 14770444
[TBL] [Abstract][Full Text] [Related]
14. The impact of hypogonadism and autonomic dysfunction on fatigue, emotional function, and sexual desire in male patients with advanced cancer: a pilot study.
Strasser F; Palmer JL; Schover LR; Yusuf SW; Pisters K; Vassilopoulou-Sellin R; DeGracia B; Willey JS; Bruera E
Cancer; 2006 Dec; 107(12):2949-57. PubMed ID: 17103445
[TBL] [Abstract][Full Text] [Related]
15. Study of anxiety disorder and depression in long-term survivors of testicular cancer.
Dahl AA; Haaland CF; Mykletun A; Bremnes R; Dahl O; Klepp O; Wist E; Fosså SD
J Clin Oncol; 2005 Apr; 23(10):2389-95. PubMed ID: 15800331
[TBL] [Abstract][Full Text] [Related]
16. Do male lymphoma survivors have impaired sexual function?
Kiserud CE; Schover LR; Dahl AA; Fosså A; Bjøro T; Loge JH; Holte H; Yuan Y; Fosså SD
J Clin Oncol; 2009 Dec; 27(35):6019-26. PubMed ID: 19858388
[TBL] [Abstract][Full Text] [Related]
17. Associations of serum testosterone with microvessel density, androgen receptor density and androgen receptor gene polymorphism in prostate cancer.
Schatzl G; Madersbacher S; Haitel A; Gsur A; Preyer M; Haidinger G; Gassner C; Ochsner M; Marberger M
J Urol; 2003 Apr; 169(4):1312-5. PubMed ID: 12629350
[TBL] [Abstract][Full Text] [Related]
18. Polymorphic repeats in the androgen receptor gene in high-risk sibships.
Miller EA; Stanford JL; Hsu L; Noonan E; Ostrander EA
Prostate; 2001 Aug; 48(3):200-5. PubMed ID: 11494335
[TBL] [Abstract][Full Text] [Related]
19. Increased risk of breast cancer in women bearing a combination of large CAG and GGN repeats in the exon 1 of the androgen receptor gene.
González A; Javier Dorta F; Rodriguez G; Brito B; Rodríguez MA; Cabrera A; Díaz-Chico JC; Reyes R; Aguirre-Jaime A; Nicolás Díaz-Chico B
Eur J Cancer; 2007 Nov; 43(16):2373-80. PubMed ID: 17728127
[TBL] [Abstract][Full Text] [Related]
20. Testosterone levels in relation to oral contraceptive use and the androgen receptor CAG and GGC length polymorphisms in healthy young women.
Hietala M; Sandberg T; Borg A; Olsson H; Jernström H
Hum Reprod; 2007 Jan; 22(1):83-91. PubMed ID: 16920725
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
